Cargando…
Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft
We previously reported that the level of microRNA (miR)-145 is attenuated in human bladder cancer cells. In this current study, we investigated whether intravesical administration of miR-145 could be a potential therapeutic strategy for controlling bladder cancer by using an orthotopic human bladder...
Autores principales: | Inamoto, Teruo, Taniguchi, Kohei, Takahara, Kiyoshi, Iwatsuki, Ayako, Takai, Tomoaki, Komura, Kazumasa, Yoshikawa, Yuki, Uchimoto, Taizo, Saito, Kenkichi, Tanda, Naoki, Kouno, Junko, Minami, Koichiro, Uehara, Hirofumi, Hirano, Hajime, Nomi, Hayahito, Kiyama, Satoshi, Akao, Yukihiro, Azuma, Haruhito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673291/ https://www.ncbi.nlm.nih.gov/pubmed/26036261 |
Ejemplares similares
-
A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder
por: Inamoto, Teruo, et al.
Publicado: (2018) -
Single session of high-intensity focused ultrasound for localized prostate cancer: treatment outcomes and potential effect as a primary therapy
por: Komura, Kazumasa, et al.
Publicado: (2013) -
Remarkable response to fluorouracil, leucovorin, oxaliplatin, and irinotecan therapy in urothelial cancer of the renal pelvis: a case report
por: Tsujino, Takuya, et al.
Publicado: (2017) -
E74-like factor inhibition induces reacquisition of hormone sensitiveness decreasing period circadian protein homolog 1 expression in prostate cancer cells()
por: Koyama, Kohei, et al.
Publicado: (2015) -
Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort
por: Komura, Kazumasa, et al.
Publicado: (2019)